Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.78 |
| ▸ | PARP1 | P09874 | 1/20 | 0.43 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.43 |
| ▸ | DRD4 | P21917 | 7/20 | 0.42 |
| ▸ | DRD2 | P14416 | 6/20 | 0.42 |
| ▸ | DRD3 | P35462 | 5/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.40 |
| ▸ | CYBB | P04839 | 1/20 | 0.37 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.37 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.37 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.36 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzpiperylon SCHEMBL24498 | 0.88 | CYP1A2 (1.00) | CYP1A2CYP3A4CYP2D6PARP1PARP2 | |
| SCHEMBL23399055 | 0.74 | ALDH1A1 (0.53) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23403138 | 0.71 | MEN1 (0.46) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23399643 | 0.70 | CYBB (0.44) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23400300 | 0.69 | MEN1 (0.58) | CYBBNOX4NOX1POLB | |
| SCHEMBL23403309 | 0.69 | MEN1 (0.57) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23403549 | 0.68 | CYBB (0.42) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23402122 | 0.68 | ALDH1A1 (0.42) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23403203 | 0.66 | ALDH1A1 (0.42) | CYP1A2CYP3A4CYP2D6CYBBNOX4 | |
| SCHEMBL23400068 | 0.65 | NOX4 (0.48) | CYP1A2CYP3A4CYP2D6CYBBNOX4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-222680545-U | Novel whole frame type diamond wire numerical control stone cutting machine tool | 青岛力凯铄石智能科技有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-222376151-U | Roof chimney structure | 四川绿静环保工程有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-118810041-A | IV type hydrogen storage pipe nylon liner hot-melt welding equipment and technology thereof | 氢劲科技(江苏)有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-114162583-B | Automatic feeding device | 浙江环龙机器有限公司 | 2024-10-15 | — | — | CN | claimed |
| CN-118493200-A | Novel whole frame type diamond wire numerical control stone cutting machine tool | 青岛力凯铄石智能科技有限公司 | 2024-08-16 | — | — | CN | claimed |
| CN-221431962-U | Falling-preventing device system for steel pipe tower | 青岛中天斯壮科技有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-115928785-B | Wind power stepped assembly type foundation applicable to mountain area and assembly method thereof | 重庆大学 | 2024-07-09 | — | — | CN | claimed |
| CN-220865182-U | Sunshade curtain extension rod structure convenient to assemble and disassemble | 江苏德福来汽车部件有限公司 | 2024-04-30 | — | — | CN | claimed |
| WO-2024081661-A1 | SYSTEMS AND METHODS FOR ELECTROCHEMICAL HYDROGEN LOOPING | CALIFORNIA INSTITUTE OF TECHNOLOGY (US) | 2024-04-18 | — | — | WO | claimed |
| CN-220785418-U | Smooth type stay cord sunshade screen extension rod structure | 江苏德福来汽车部件有限公司 | 2024-04-16 | — | — | CN | claimed |
| WO-2004082719-A1 | DISPERSIBLE PHARMACEUTICAL COMPOSITION FOR TREATMENT OF MASTITIS AND OTIC DISORDERS | PHARMACIA CORPORATION (US) | 2004-09-30 | — | — | WO | claimed |
| WO-2004082588-A2 | DISPERSIBLE FORMULATION OF AN ANTI-INFLAMMATORY AGENT | PHARMACIA CORPORATION (US) | 2004-09-30 | — | — | WO | claimed |
| US-20040156872-A1 | Novel nimesulide compositions | ELAN PHARMA INTERNATIONAL LTD. | 2004-08-12 | — | — | US | claimed |
| US-20030235617-A1 | Pharmaceutical dosage form for mucosal delivery | MCNEIL-PPC, INC | 2003-12-25 | — | — | US | claimed |
| US-20030180357-A1 | Pharmaceutical tablet | MCNEIL-PPC, INC | 2003-09-25 | — | — | US | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
| WO-2003066029-A2 | PHARMACEUTICAL DOSAGE FORM FOR MUCOSAL DELIVERY | PHARMACIA CORPORATION (US) | 2003-08-14 | — | — | WO | claimed |
| WO-2003066030-A2 | PHARMACEUTICAL TABLET | PHARMACIA CORPORATION (US) | 2003-08-14 | — | — | WO | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040156872-A1 | Novel nimesulide compositions | NIM1K, NIT2, NCL | CYP1A2 3009/4885CYP3A4 1976/4885CYP2D6 1359/4885 |
| US-20030180357-A1 | Pharmaceutical tablet | GYPA, SORD, SRI | CYP1A2 1609/4885CYP3A4 306/4885CYP2D6 252/4885 |
| US-20030235617-A1 | Pharmaceutical dosage form for mucosal delivery | SI, UGGT1, GYPA | CYP1A2 588/4885CYP3A4 67/4885CYP2D6 68/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.